{"id":233062,"date":"2026-03-11T10:11:42","date_gmt":"2026-03-11T15:11:42","guid":{"rendered":"https:\/\/lifeboat.com\/blog\/2026\/03\/long-term-treatment-with-interleukin-6-receptor-inhibitor-tocilizumab-in-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease"},"modified":"2026-03-11T10:11:42","modified_gmt":"2026-03-11T15:11:42","slug":"long-term-treatment-with-interleukin-6-receptor-inhibitor-tocilizumab-in-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease","status":"publish","type":"post","link":"https:\/\/lifeboat.com\/blog\/2026\/03\/long-term-treatment-with-interleukin-6-receptor-inhibitor-tocilizumab-in-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease","title":{"rendered":"Long-Term Treatment With Interleukin-6 Receptor Inhibitor Tocilizumab in Myelin Oligodendrocyte Glycoprotein Antibody\u2013Associated Disease"},"content":{"rendered":"<p><a class=\"aligncenter blog-photo\" href=\"https:\/\/lifeboat.com\/blog.images\/long-term-treatment-with-interleukin-6-receptor-inhibitor-tocilizumab-in-myelin-oligodendrocyte-glycoprotein-antibody-associated-disease2.jpg\"><\/a><\/p>\n<p>This longitudinal, retrospective study found that the interleukin-6 receptor inhibitor tocilizumab shows promise as a potentially effective treatment in MOGAD, and its subcutaneous administration may improve long-term therapy adherence.<\/p>\n<hr>\n<p>Background and Objectives.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>This longitudinal, retrospective study found that the interleukin-6 receptor inhibitor tocilizumab shows promise as a potentially effective treatment in MOGAD, and its subcutaneous administration may improve long-term therapy adherence. Background and Objectives.<\/p>\n","protected":false},"author":662,"featured_media":0,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[11],"tags":[],"class_list":["post-233062","post","type-post","status-publish","format-standard","hentry","category-biotech-medical"],"_links":{"self":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/233062","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/users\/662"}],"replies":[{"embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/comments?post=233062"}],"version-history":[{"count":0,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/posts\/233062\/revisions"}],"wp:attachment":[{"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/media?parent=233062"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/categories?post=233062"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/lifeboat.com\/blog\/wp-json\/wp\/v2\/tags?post=233062"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}